Cover Image

Dual-criterion Dose Finding Designs Based on Dose-Limiting Toxicity and Tolerability

Fuente: arXiv

Saved in:

Bibliographic Details
Main Authors:	Yang, Yunlong, Yuan, Ying
Format:	Preprint
Published:	2024
Subjects:	Methodology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

BE-BOIN: A Dose Optimization Design Accommodating Backfill and Late-Onset Toxicity
by: Chen, Kai, et al.
Published: (2025)

Statistical Operating Characteristics of Current Early Phase Dose Finding Designs with Toxicity and Efficacy in Oncology
by: Sun, Hao, et al.
Published: (2024)

ROSE: Randomized Optimal Selection Design for Dose Optimization
by: Wang, Shuqi, et al.
Published: (2025)

BOP2-TE: Bayesian Optimal Phase 2 Design for Jointly Monitoring Efficacy and Toxicity with Application to Dose Optimization
by: Chen, Kai, et al.
Published: (2024)

A Likelihood Perspective on Dose-Finding Study Designs in Oncology
by: Zhang, Zhiwei
Published: (2023)

Precision Dose-Finding Design for Phase I Oncology Trials by Integrating Pharmacology Data
by: Lee, Kyong Ju, et al.
Published: (2025)

Bayesian Optimization for Identification of Optimal Biological Dose Combinations in Personalized Dose-Finding Trials
by: Willard, James, et al.
Published: (2024)

Utility-Based Dose Optimization Approaches for Multiple-Dose Randomized Trial Designs Accounting for Multiple Endpoints
by: DAngelo, Gina, et al.
Published: (2025)

LORDs: Locally Optimal Restricted Designs for Phase I/II Dose-Finding Studies
by: Sverdlov, Oleksandr, et al.
Published: (2025)

ROMI: A Randomized Two-Stage Basket Trial Design to Optimize Doses for Multiple Indications
by: Wang, Shuqi, et al.
Published: (2024)

Bayesian Optimization for Personalized Dose-Finding Trials with Combination Therapies
by: Willard, James, et al.
Published: (2023)

BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials
by: Chen, Yuxuan, et al.
Published: (2026)

Personalized Two-sided Dose Interval
by: Park, Chan, et al.
Published: (2023)

An Adaptive Phase II Trial Design for Dose Selection and Addition in Microfilarial Infections
by: Zehetmayer, Sonja, et al.
Published: (2026)

TWICEBEE: A Two-stage Intra-patient Curve-free Bayesian Decision-Theoretic Dose Escalation Design
by: Bi, Dehua, et al.
Published: (2026)

Defining Utility as a Measure of Preference Under Uncertainty in Phase I-II Oncology Dose Finding Trials
by: Hall, Andrew, et al.
Published: (2025)

CUI-MET: Clinical Utility Index Dose Optimization Approach for Multiple-Dose, Multiple-Outcome Randomized Trial Designs
by: Zhang, Fanni, et al.
Published: (2025)

A Seamless Phase II/III Design with Dose Optimization for Oncology Drug Development
by: Li, Yuhan, et al.
Published: (2024)

Hybrid Non-informative and Informative Prior Model-assisted Designs for Mid-trial Dose Insertion
by: Yamada, Kana, et al.
Published: (2026)

Bridging the Gap Between Design and Analysis: Randomization Inference and Sensitivity Analysis for Matched Observational Studies with Treatment Doses
by: Zhang, Jeffrey, et al.
Published: (2024)

HAL-Based Plug-in Estimation with Pointwise Asymptotic Normality of the Causal Dose-Response Curve
by: Shi, Junming, et al.
Published: (2024)

DEMO: Dose Exploration, Monitoring, and Optimization Using a Biological Mediator for Clinical Outcomes
by: Yang, Cheng-Han, et al.
Published: (2024)

Extreme Treatment Effect: Extrapolating Dose-Response Function Into Extreme Treatment Domain
by: Bodik, Juraj
Published: (2024)

Two-dose vs. Three-Dose Optimization Under Sample Size Constraint
by: Sun, Linda, et al.
Published: (2026)

Adaptive Weighting for Time-to-Event Continual Reassessment Method: Improving Safety in Phase I Dose-Finding Through Data-Driven Delay Distribution Estimation
by: Amevor, Robert, et al.
Published: (2026)

A Utility Score Framework for Dose Optimization Studies with Binary Efficacy-Safety Endpoints: Sample Size Determination and Bias Characterization
by: Gu, Xuemin, et al.
Published: (2026)

Feasible Dose-Response Curves for Continuous Treatments Under Positivity Violations
by: Bao, Han, et al.
Published: (2025)

Dose optimization design accounting for unknown patient heterogeneity in cancer clinical trials
by: Silva, Rebecca B., et al.
Published: (2025)

Estimands for Early Phase Dose Optimization Trials in Oncology
by: Mukherjee, Ayon, et al.
Published: (2025)

Evaluating Bias Reduction Methods in Binary Emax Model for Reliable Dose-Response Estimation
by: Zhang, Jiangshan, et al.
Published: (2025)

Sequential Kernel Embedding for Mediated and Time-Varying Dose Response Curves
by: Singh, Rahul, et al.
Published: (2021)

Robust Emax Model Fitting: Addressing Nonignorable Missing Binary Outcome in Dose-Response Analysis
by: Zhang, Jiangshan, et al.
Published: (2024)

Akaike information criterion for segmented regression models
by: Nakajima, Kazuki, et al.
Published: (2025)

Posterior covariance information criterion for general loss functions
by: Iba, Yukito, et al.
Published: (2022)

An information criterion for detecting periodicities in functional time series
by: Sagawa, Rinka, et al.
Published: (2026)

U-DESPE: a Bayesian Utility-based methodology for dosing regimen optimization in early-phase oncology trials based on Dose-Exposure, Safety, Pharmacodynamics, Efficacy
by: Andrillon, Anaïs, et al.
Published: (2025)

Design-Based Ratio Estimators and Central Limit Theorems for Clustered, Blocked RCTs
by: Schochet, Peter Z., et al.
Published: (2020)

A criterion and incremental design construction for simultaneous kriging predictions
by: Waldl, Helmut, et al.
Published: (2023)

Design-Based Estimation and Central Limit Theorems for Local Average Treatment Effects for RCTs
by: Schochet, Peter Z
Published: (2024)

Latent Theme Dictionary Model for Finding Co-occurrent Patterns in Process Data
by: Fang, Guanhua, et al.
Published: (2019)